Ependymoma in children under the age of 3 years: a report from the Canadian Pediatric Brain Tumour Consortium

2014 ◽  
Vol 117 (2) ◽  
pp. 359-364 ◽  
Author(s):  
Eve Purdy ◽  
Donna L. Johnston ◽  
Ute Bartels ◽  
Chris Fryer ◽  
Anne-Sophie Carret ◽  
...  
2016 ◽  
Vol 120 ◽  
pp. S17-S18
Author(s):  
Dominique Fortin ◽  
Angela Ng ◽  
Derek Tsang ◽  
Michael Sharpe ◽  
Normand Laperriere ◽  
...  

2014 ◽  
Vol 31 (1) ◽  
pp. 57-65 ◽  
Author(s):  
Tamir Ailon ◽  
Christopher Dunham ◽  
Anne-Sophie Carret ◽  
Uri Tabori ◽  
P. Daniel Mcneely ◽  
...  

2015 ◽  
Vol 124 (1) ◽  
pp. 95-100 ◽  
Author(s):  
Donna L. Johnston ◽  
Daniel Keene ◽  
Ute Bartels ◽  
Anne-Sophie Carret ◽  
Bruce Crooks ◽  
...  

2020 ◽  
Vol 22 (Supplement_3) ◽  
pp. iii431-iii431
Author(s):  
Chantel Cacciotti ◽  
Adam Fleming ◽  
Hanna Tseitlin ◽  
JoAnn Duckworth ◽  
Stacey Marjerrison

Abstract OBJECTIVES Pediatric brain tumour survivors are at risk of long-term consequences of therapy. Comprehensive late effects care may mitigate these risks, but the best care model is unclear. We sought to describe the care experience and quality of life (QOL) of pediatric brain tumour survivors at the McMaster Children’s Hospital joint adult/pediatric Neuro-Oncology clinic. METHODS Cross-sectional survey data were collected. Care needs were assessed with the Cancer Care Experience Questionnaire (CCEQ), Cancer Worry Scale (CWS), and Self-Management Skills Scale (SMSS). Quality of life was measured utilizing the PedsQL Brain Tumor Module. Data were analyzed descriptively. RESULTS Thirty-two childhood brain tumor survivors and/or their parents participated. Their malignancies included embryonal tumors (medulloblastoma/ATRT) (62%), ependymoma (22%), and germ cell tumours (16%). Among 77%, therapy included chemotherapy, surgery and radiation. Most respondents reported high quality cancer care, although some could not recall discussions of late effects risks and health promotion. Mean cancer worry scores were low (71.8 (± 28.4)). Survivors reported limited self-management skills (58.5 (±18.2)), with support required in clinic visits, arranging medical appointments, filling prescriptions and tasks of daily living. Overall median QOL scores were in the ‘good’ range (parental report 72.3 (±17.7), survivor 68.2 (±16.6)). CONCLUSION In comparison to other childhood cancer survivor cohorts, this group of long-term brain tumour survivors appear to have similar QOL, fewer cancer worries, and increased need for aid with self-management. Given this, along with the positive care experience reported, this clinic model of care appears to meet the needs of this population.


Sign in / Sign up

Export Citation Format

Share Document